scispace - formally typeset
M

Matilde Masini

Researcher at University of Pisa

Publications -  92
Citations -  11006

Matilde Masini is an academic researcher from University of Pisa. The author has contributed to research in topics: Insulin & Pancreatic islets. The author has an hindex of 34, co-authored 89 publications receiving 9395 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Prolonged Exposure to Free Fatty Acids Has Cytostatic and Pro-Apoptotic Effects on Human Pancreatic Islets: Evidence that β-Cell Death Is Caspase Mediated, Partially Dependent on Ceramide Pathway, and Bcl-2 Regulated

TL;DR: Extended exposure to FFAs has cytostatic and pro-apoptotic effects on human pancreatic beta-cells, likely to be due to the FFA-induced reduction of intraislet glucose metabolism, and the proapoptosis effects are mostly caspase mediated, partially dependent on ceramide pathway, and possibly Bcl-2 regulated.
Journal ArticleDOI

Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes

TL;DR: 24-h exposure to glutathione significantly improved glucose-stimulated insulin release and decreased nitrotyrosine concentration, with partial recovery of insulin mRNA expression, providing direct evidence that the defects of insulin secretion in type 2 diabetic islets are associated with multiple islet cell alterations.
Journal ArticleDOI

Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes

TL;DR: The data support the view that pancreatic β-cells become dedifferentiated and convert to α- and δ-"like" cells in human type 2 diabetes, and should prompt a reassessment of goals in the prevention and treatment of β-cell dysfunction.